Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
about
Mechanism of the sex difference in endothelial dysfunction after strokeEpoxyeicosatrienoic acids and cardioprotection: the road to translationA 3'-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant RecipientsProtective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channelsRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceProtective effect of 20-HETE analogues in experimental renal ischemia reperfusion injuryPeroxisome proliferator-activated receptor γ is essential for secretion of ANP induced by prostaglandin D2 in the beating rat atrium.eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of ChinaA cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospitalCytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients.Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi.CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophyDeletion of the murine cytochrome P450 Cyp2j locus by fused BAC-mediated recombination identifies a role for Cyp2j in the pulmonary vascular response to hypoxiaEpoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j.Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures.Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.Pretreatment with low-dose gadolinium chloride attenuates myocardial ischemia/reperfusion injury in ratsPhospholipid-mediated signaling systems as novel targets for treatment of heart disease.Ischemic Preconditioning And Myocardial Infarction: An Update and Perspective.Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism.15-deoxy-Δ¹²,¹⁴-PGJ₂ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis.Ischemia/Reperfusion.The cardioprotection of dihydrotanshinone I against myocardial ischemia-reperfusion injury via inhibition of arachidonic acid ω-hydroxylase.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.Factors mediating remote preconditioning of trauma in the rat heart: central role of the cytochrome p450 epoxygenase pathway in mediating infarct size reduction.Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.Haplotype-based case-control study of CYP4A11 gene and myocardial infarction.Systems Pharmacology Dissection of the Protective Effect of Myricetin Against Acute Ischemia/Reperfusion-Induced Myocardial Injury in Isolated Rat Heart.
P2860
Q27001603-AE5F478F-0A86-4557-B8C1-95B10EA8BC93Q28241262-0DD1CF85-772B-4FD4-8C61-876713F5BDDAQ28384776-B12F261A-6B87-4889-AF5B-908F45422530Q28392794-2145842D-A817-4DE6-BCE8-519D4E63E4F5Q28398028-4B7D7279-4940-4197-9F63-4BD81FA93739Q33389156-16D99FE8-92D3-4B81-AF47-FA82D8B26550Q33614741-86642F35-5AC6-43DC-B74D-C662630D979BQ34092872-8AB81EAE-0A82-433D-8576-7F19E79B9D14Q34143118-A709EF59-D899-45D2-A89E-009C917415EDQ34246447-7F10554C-C1C7-4510-91C8-D015BD055442Q34259503-BBBAA605-BCBB-4A41-94D7-4BBBA4B31251Q34358307-C66B4177-2979-4438-9503-C9F6B4E57A47Q34495642-654178CB-2248-49C3-98F4-D1CD651C1AA0Q34604156-E1C66196-BC86-4E9F-B1C5-FEADEAECAD96Q34983743-755C3A14-A745-4B36-950B-9F601A0F8F58Q35053073-5D82507B-D088-4233-B3D0-D09DB3406006Q35747774-D02776BC-B5BD-4E5A-AC38-32E04FC03F56Q35816434-AAFD0AAD-D6ED-4C89-81A3-E7E27F5F97E4Q35850108-4B349D98-89C7-4B8C-8BAA-1556BE77F75DQ35994164-B6F94E6C-7D7E-4D6E-ABF1-7750C645944FQ36461800-75D51A0D-F479-432F-A31B-623330C89467Q36658386-B3192F75-9F9A-417A-A78F-52C42B869EDEQ36765109-E5418C4E-6402-4271-B2EF-09A18D896DE5Q36814743-585F3035-A59C-4EB4-AB0D-129782C45729Q37243210-0156F4EA-7900-4487-A9A4-8470CBE99A89Q37264451-A5F82130-8712-405E-8208-770149D153D3Q38622658-80CD2D0E-B474-4B79-BE85-33AFEB09EA77Q38825803-7E6C940E-C861-41D0-879C-0954F06A1A3BQ38918680-B271D908-8DDF-4FCF-BF4E-1CA7E82E456FQ39008479-E3572965-1130-4E78-A054-7038D651DB6BQ39109413-391D41D8-D700-4301-B872-5A64118B8AAFQ39435842-BB5C0A91-0CE8-4A48-83F3-4E38B38C5F09Q41432422-91DCFDA2-243C-4089-A78F-66E9BF912161Q41653338-B3C6DF7E-BF98-4A45-8B37-25FFF86C2EC7Q42326771-FA3C5CEE-3DF5-4478-9FEB-998FF2B18D41Q42912792-AAF09129-D833-4977-8BD0-BDC7E5B4DB81Q42926298-5CFF9288-83FB-412B-A14F-4C7D20588141Q46724132-07A0F401-D5E0-4AFC-92D9-C7D42BB902BDQ46749490-2C42352D-44ED-49A5-BA4B-192C53C6D3E4Q48130880-AD9FB659-7A23-4129-93F7-1CD4CF45E9CB
P2860
Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@ast
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@en
type
label
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@ast
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@en
prefLabel
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@ast
Cytochrome P450 and arachidoni ...... /reperfusion injury revisited.
@en
P2093
P1476
Cytochrome P450 and arachidoni ...... a/reperfusion injury revisited
@en
P2093
Eric R Gross
Garrett J Gross
Jeannine Moore
Kasem Nithipatikom
Marilyn Isbell
P356
10.1016/J.CARDIORES.2005.06.007
P577
2005-10-01T00:00:00Z